Enbridge Inc
ENB
TC Energy Corp
TRP
The Toronto-Dominion Bank
TD
TELUS Corp
T
Emera Inc
EMA
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -50.35%337.43K | -69.43%166.02K | -0.58%134.6K | 146.75%1.57M | 166.55%210.33K | 363.66%679.61K | 210.67%543.18K | -42.48%135.38K | -73.85%635.67K | -77.39%78.91K |
Selling and administrative expenses | -69.00%70.32K | -2.48%68.63K | 88.42%45.84K | 4.69%370.4K | 276.61%48.83K | 493.65%226.87K | -56.72%70.38K | -82.62%24.33K | -22.08%353.81K | -88.61%12.97K |
-Selling and marketing expense | -14.62%37.4K | -29.61%12.02K | 6.83%7.44K | -62.75%88.78K | 108.86%20.94K | 618.54%43.8K | -87.77%17.07K | -91.57%6.97K | --238.35K | --10.03K |
-General and administrative expense | -82.02%32.92K | 6.21%56.62K | 121.15%38.4K | 143.90%281.62K | 849.15%27.89K | 469.95%183.06K | 131.11%53.31K | -69.72%17.36K | -74.57%115.46K | -97.42%2.94K |
Other operating expenses | -41.00%267.11K | -79.40%97.39K | -20.08%88.75K | 325.06%1.2M | 144.92%161.5K | 317.82%452.74K | 3,766.23%472.8K | 16.48%111.05K | -85.74%281.86K | -71.96%65.94K |
Operating profit | 50.35%-337.43K | 69.43%-166.02K | 0.58%-134.6K | -146.75%-1.57M | -166.55%-210.33K | -363.66%-679.61K | -210.67%-543.18K | 42.48%-135.38K | 73.85%-635.67K | 77.39%-78.91K |
Net non-operating interest income (expenses) | ||||||||||
Other net income (expenses) | 56.43%-15.25K | -6.75K | -24K | -91.67%-80.5K | -45.5K | -35K | -310.00%-42K | |||
Gain on sale of security | 56.43%-15.25K | ---6.75K | ---24K | -91.67%-80.5K | ---45.5K | ---35K | ---- | ---- | ---42K | ---- |
Income before tax | 50.65%-352.68K | 68.19%-172.77K | -17.15%-158.6K | -143.33%-1.65M | -111.59%-255.83K | -387.54%-714.61K | -210.67%-543.18K | 42.48%-135.38K | 71.89%-677.67K | 63.25%-120.91K |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | 50.65%-352.68K | 68.19%-172.77K | -17.15%-158.6K | -143.33%-1.65M | -111.59%-255.83K | -387.54%-714.61K | -210.67%-543.18K | 42.48%-135.38K | 71.89%-677.67K | 63.25%-120.91K |
Net income continuous operations | 50.65%-352.68K | 68.19%-172.77K | -17.15%-158.6K | -143.33%-1.65M | -111.59%-255.83K | -387.54%-714.61K | -210.67%-543.18K | 42.48%-135.38K | 71.89%-677.67K | 63.25%-120.91K |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 50.65%-352.68K | 68.19%-172.77K | -17.15%-158.6K | -143.33%-1.65M | -111.59%-255.83K | -387.54%-714.61K | -210.67%-543.18K | 42.48%-135.38K | 71.89%-677.67K | 63.25%-120.91K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 50.65%-352.68K | 68.19%-172.77K | -17.15%-158.6K | -143.33%-1.65M | -111.59%-255.83K | -387.54%-714.61K | -210.67%-543.18K | 42.48%-135.38K | 71.89%-677.67K | 63.25%-120.91K |
Diluted earnings per share | 70.00%-0.003 | 68.43%-0.0015 | -14.08%-0.0014 | 0.00%-0.01 | 0 | -665.11%-0.01 | -204.81%-0.0048 | 42.47%-0.0012 | 50.00%-0.01 | -0.005 |
Basic earnings per share | 70.00%-0.003 | 68.43%-0.0015 | -14.08%-0.0014 | 0.00%-0.01 | 0 | -665.11%-0.01 | -204.81%-0.0048 | 42.47%-0.0012 | 50.00%-0.01 | -0.005 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.